Roche Obesity Shot Led to 18% Weight Loss in Study
Roche Holding AG said patients on its experimental shot lost 18% more weight than those who got placebo…
Roche and Zealand Report 10.7% Weight Loss With Experimental Obesity Drug
An experimental obesity shot from Roche Holding AG and Zealand Pharma A/S failed to meet industry expectations in…
Roche (ROG) Raises Annual Profit Forecast as New Drugs Buoy Sales
Roche Holding AG raised its 2024 profit forecast as new drugs like Vabysmo for eye disease drove revenue…
Roche Pursues Muscle-Growth Research in Obesity as Neuromuscular Work Ends
Roche Holding AG said it plans to keep studying an experimental compound for its muscle-growth potential during weight…
Roche Hires Novo Executive to Help Push Into Obesity Drug Market
Roche Holding AG hired a senior executive from rival Novo Nordisk A/S as the Swiss drugmaker prepares to…
Roche Issues Prudent Forecast as Eye Drug’s Sales Disappoint
Roche Holding AG reported disappointing revenue for a blockbuster eye medicine and lackluster growth predictions for the year.…